MedTrace Logo

Ultrasound-Guided Infraclvicular Block Using Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Upper Limb Orthopedic Surgery

NCT07279727 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-12-12

No results posted yet for this study

Summary

this study is designed to evaluate and compare the efficacy of dexmedetomidine and nalbuphine as adjuvants to 0.5% bupivacaine in ultrasound-guided infraclavicular brachial plexus block for patients undergoing elective upper limb orthopedic surgeries on the duration of analgesia.

Conditions

  • Regional Anaesthesia

Interventions

DRUG

Nalbuphine

Nalbuphine will be added to .5% bupivacaine as an adjuvant in infraclavicular nerve block

DRUG

Dexmedetomidine

Dexmedetomidine will be added to .5% bupivacaine as an adjuvant in infraclavicular nerve block

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Momen mostafa meki, Dr · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-12-31
Completion
2027-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07279727 on ClinicalTrials.gov